19-45529183-T-A
Variant names:
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 2P and 6B. PM1BP4_StrongBP6_Moderate
The NM_001017989.3(OPA3):c.416A>T(p.Gln139Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000142 in 1,610,392 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.00016 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00014 ( 0 hom. )
Consequence
OPA3
NM_001017989.3 missense
NM_001017989.3 missense
Scores
3
4
9
Clinical Significance
Conservation
PhyloP100: 1.58
Genes affected
OPA3 (HGNC:8142): (outer mitochondrial membrane lipid metabolism regulator OPA3) The mouse ortholog of this protein co-purifies with the mitochondrial inner membrane. Mutations in this gene have been shown to result in 3-methylglutaconic aciduria type III and autosomal dominant optic atrophy and cataract. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2009]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -4 ACMG points.
PM1
In a chain Optic atrophy 3 protein (size 177) in uniprot entity OPA3_HUMAN there are 7 pathogenic changes around while only 3 benign (70%) in NM_001017989.3
BP4
Computational evidence support a benign effect (MetaRNN=0.04952064).
BP6
Variant 19-45529183-T-A is Benign according to our data. Variant chr19-45529183-T-A is described in ClinVar as [Likely_benign]. Clinvar id is 790939.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000158 AC: 24AN: 152140Hom.: 0 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
24
AN:
152140
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000242 AC: 58AN: 240124 AF XY: 0.000243 show subpopulations
GnomAD2 exomes
AF:
AC:
58
AN:
240124
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000141 AC: 205AN: 1458252Hom.: 0 Cov.: 31 AF XY: 0.000153 AC XY: 111AN XY: 725646 show subpopulations
GnomAD4 exome
AF:
AC:
205
AN:
1458252
Hom.:
Cov.:
31
AF XY:
AC XY:
111
AN XY:
725646
Gnomad4 AFR exome
AF:
AC:
0
AN:
33472
Gnomad4 AMR exome
AF:
AC:
0
AN:
44662
Gnomad4 ASJ exome
AF:
AC:
101
AN:
26086
Gnomad4 EAS exome
AF:
AC:
0
AN:
39692
Gnomad4 SAS exome
AF:
AC:
0
AN:
86224
Gnomad4 FIN exome
AF:
AC:
4
AN:
50420
Gnomad4 NFE exome
AF:
AC:
83
AN:
1111624
Gnomad4 Remaining exome
AF:
AC:
17
AN:
60320
Heterozygous variant carriers
0
13
26
39
52
65
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.000158 AC: 24AN: 152140Hom.: 0 Cov.: 31 AF XY: 0.000135 AC XY: 10AN XY: 74326 show subpopulations
GnomAD4 genome
AF:
AC:
24
AN:
152140
Hom.:
Cov.:
31
AF XY:
AC XY:
10
AN XY:
74326
Gnomad4 AFR
AF:
AC:
0
AN:
0
Gnomad4 AMR
AF:
AC:
0
AN:
0
Gnomad4 ASJ
AF:
AC:
0.00432277
AN:
0.00432277
Gnomad4 EAS
AF:
AC:
0
AN:
0
Gnomad4 SAS
AF:
AC:
0
AN:
0
Gnomad4 FIN
AF:
AC:
0
AN:
0
Gnomad4 NFE
AF:
AC:
0.000132306
AN:
0.000132306
Gnomad4 OTH
AF:
AC:
0
AN:
0
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
2
ExAC
AF:
AC:
23
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
3-Methylglutaconic aciduria type 3;C1833809:Optic atrophy 3 Benign:1
Nov 10, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
DANN
Uncertain
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
T
M_CAP
Pathogenic
D
MetaRNN
Benign
T
MetaSVM
Benign
T
PrimateAI
Benign
T
PROVEAN
Pathogenic
D
REVEL
Uncertain
Sift
Uncertain
D
Sift4G
Uncertain
D
Polyphen
P
Vest4
MVP
MPC
ClinPred
T
GERP RS
gMVP
Mutation Taster
=71/29
polymorphism
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at